Screener
Cyclerion Therapeutics CYCN Q2 2026 earnings
Reported August 4, 2026 · Before market open
EPS-$0.41Beat by $6.69
Revenue estimate$1.5M
EPS estimate-$7.10
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$900.0K
EPS estimate-$6.00
Versus estimates
Diluted EPS
Q2 2026-$0.41Beat by $6.69
Q1 2026-$0.76Beat by $16.44Q4 2025-$0.19Beat by $0.19Q1 2024-$0.38In lineQ3 2025-$0.30Q2 2025-$0.11FAQ
- When did Cyclerion Therapeutics report Q2 2026 earnings?
- Cyclerion Therapeutics (CYCN) reported Q2 2026 earnings on August 4, 2026 before market open.
- What were Cyclerion Therapeutics's Q2 2026 revenue and EPS?
- Cyclerion Therapeutics reported eps of $-0.41 for Q2 2026.
- Did Cyclerion Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-7.10 by $6.69.
- How did Cyclerion Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 272.7% from $-0.11.
- Where can I find Cyclerion Therapeutics's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-332842) directly on SEC EDGAR. The filing index links above go to sec.gov.
